JC Virus: JCV, PML, and DNA Frequency

Herbert Eder – an internationally sought-after frequency expert

The JC virus, or JCV for short, belongs to the polyomavirus family. Many people come into contact with it at some point in their lives without developing a serious illness. In cases of severe immunodeficiency, the virus can cause progressive multifocal leukoencephalopathy (PML). However, a general virus designation and the individual frequency figure do not constitute a diagnosis of this rare neurological disorder.

A widespread viral exposure does not automatically mean PML

Evidence of previous exposure to JCV must be distinguished from a brain disease. PML affects the brain's white matter and occurs particularly in certain situations where the immune system is compromised. An individual's risk cannot be calculated based on the presence of a name in a database.

Similarly, a subjective frequency response cannot confirm or rule out such a risk. The list does not contain any information about a person’s medications, immune status, or neurological findings. It should therefore not be interpreted as a general self-test for a serious illness. A program title does not provide any additional diagnostic certainty.

Neurological changes require appropriate medical evaluation

When PML is suspected, clinical examination, imaging, and, if applicable, specific laboratory findings are evaluated together. A single result without a relevant context is not sufficient for any diagnostic determination. The decision regarding necessary tests should be left to experts.

New or worsening neurological symptoms should not be assessed based on a frequency list. Sudden-onset deficits, in particular, require immediate medical attention, especially since other urgent causes may be involved. A suspected reaction to JCV does not replace an examination of the nervous system or the evaluation of other possible conditions and must not delay necessary care.

The immune status plays a key role in care

If PML is confirmed, care from a specialist is crucial. An important treatment goal may be to restore or improve immune function. How this can be achieved depends on the underlying condition and the existing treatments. Therefore, no general recommendation for self-treatment can be made.

In particular, immunosuppressive or antiretroviral medications must not be changed on one’s own initiative based solely on a frequency reading. This value does not indicate that the virus has been eliminated or that damaged nerve structures have been restored. Even a subjective improvement is no substitute for appropriate follow-up care. Decisions must be based on actual test results and the care provided by the treatment team.

14,116 Hz is not an indicator of neurological risk

The original entry "JC Virus" contains 14,116 Hz. The value is reported without conversion. It is neither an antibody index nor a measurement of viral DNA, nor does it indicate a specific testing site. Such clinical meanings are not retroactively attributed to the number.

Nor are the duration and intensity of use documented there. Inclusion in a database does not confirm clinical efficacy against JCV or PML. The following table is intended solely to provide a clear representation of the existing entry and does not serve as a basis for decisions regarding the initiation, continuation, or discontinuation of medical therapy.

DNA Sequences for the JC Virus: Database Information

The DNA frequency database used contains the following mappings. The values remain unchanged in Hz; the period serves as a thousands separator.

Original Name Frequency
JC Virus 14,116 Hz

This association does not substantiate a measured natural frequency or any diagnostic or therapeutic effect. A verifiable derivation from a specific DNA sequence and clinical evidence of efficacy are not documented in the entries provided. No recommendations regarding duration, intensity, or application are derived from the numbers; there is no automatic octave adjustment.

Note: Frequency therapy is not recognized by conventional medicine and is not a substitute for a medical diagnosis or treatment, or for necessary veterinary care. Necessary medical measures must not be delayed as a result.

author avatar
Herbert Eder
Herbert Eder is a frequency researcher, frequency therapist, author, and instructor. He has been working in the fields of frequency therapy and information medicine since 1994. On herbert-eder.com, he provides accessible expert knowledge, shares insights from his many years of practice, and highlights developments in frequency research—while taking a responsible approach to potential applications and limitations.